Abbott launches pivotal US-based Tendyne TMVR trial

cafead

Administrator
Staff member
  • cafead   Jul 26, 2018 at 11:42: AM
via Abbott (NYSE:ABT) said today it launched a US-based pivotal clinical study of its Tendyne transcatheter mitral valve replacement system designed to treat mitral regurgitation.

article source